跳至主要内容
临床试验/CTRI/2024/05/067575
CTRI/2024/05/067575招募中3 期

Randomized Controlled Study on the Efficacy of Punctal Cautery in severe Dry Eye disease

L V Prasad Eye Institute1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年5月30日最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
50
试验地点
1
主要终点
Change in dry eye symptoms assessed using validated questionnaires such as the Ocular Surface Disease Index (OSDI) score.

研究概览

简要总结

Dry eye syndrome (DES) is a prevalent ocular condition characterized by a disruption in tear film stability and ocular surface inflammation, leading to symptoms such as ocular discomfort, visual disturbances, and, in severe cases, corneal damage. Punctal cautery, a minimally invasive procedure involving the thermal occlusion of puncta, has been suggested as a potential therapeutic option for dry eye disease (DED). However, evidence on its efficacy and safety is limited, necessitating a randomized controlled trial to evaluate its utility in managing DES.

Primary outcomes are change in Schirmer value and dry eye symptoms (OSDI) at 3 months follow-up. Secondary outcomes are change in tear break-up time, corneal fluorescein and conjunctival Lissamine staining scores, tear meniscus height and bulbar redness.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
5.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Aged 5–70 years
  • Have OSDI scores ≥33 or Oxford staining grade ≥2
  • Diagnosis of DED in both eyes supported by the criteria mentioned below a.A symptom severity score of ≥33 for OSDI b.An unanesthetized Schirmer Tear Test (STT) score of ≥1 mm and ≤5 mm per 5 minutes c.Evidence of ocular surface staining (total fluorescein staining score of at least 3) [0-15 scale])
  • Have normal lid anatomy and diagnosed with severe dry eye (ATDDE)
  • DED refractory to medical management.

排除标准

  • 1.History of punctal occlusion or punctal dilation.
  • 2.Active ocular infection or inflammation.
  • 3.Use of punctal plugs within the past 3 months.
  • 4.Pregnancy or lactation women.
  • 5.Any systemic or ocular condition that may interfere with the study assessments or participant safety.
  • 6.Punctal plug or contact lenses.
  • Have no contraindication for blood donation 8.Positive HIV, hepatitis B or C, or syphilis.

结局指标

主要结局

Change in dry eye symptoms assessed using validated questionnaires such as the Ocular Surface Disease Index (OSDI) score.

时间窗: 1 month, 3 months

次要结局

  • Visual Acuity, Adverse events related to intervention(1 month and 3 months)

研究者

申办方类型
Other [Not for profit]
责任方
Principal Investigator
主要研究者

DrSwati Singh

L V Prasad Eye Institute

研究点 (1)

Loading locations...

相似试验